发明授权
US08227613B2 Heteroaryl carboxamide derivatives 失效
杂芳基甲酰胺衍生物

Heteroaryl carboxamide derivatives
摘要:
The invention is concerned with novel heteroaryl carboxamide derivatives of formula (I), wherein m, X, Y, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
公开/授权文献
信息查询
0/0